Article Details

PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B

Retrieved on: 2021-02-03 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

PAOG Highlights Its Own Cannabis Pharma Tech As GW Pharma Valued At $7.2 B. View article details on hiswai:

Excerpt

RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) ... PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up